https://www.biopharma-reporter.com/Article/2023/02/14/vaxxas-begins-clinical-trial-of-first-needle-free-inactivated-seasonal-flu-vaccine
0
0
2/14/23 at 9:59am
Organization
BioPharma-Reporter.com
Author
biopharma-reporter.com
37 words
0
Comments
Australia’s Vaxxas has initiated a Phase I clinical trial with the first needle-free inactivated seasonal influenza vaccine quadrivalent (IIV4) candidate.
You are the first to view
Create an account
or login to join the discussion